LIAISON Test for Respiratory Infections

A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients

Recruiting N/A Interventional Study
Influenza a Influenza B RSV COVID 19
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
1,000 (estimated)
Sponsor
DiaSorin Molecular LLC · Industry
Who this trial is looking for

This trial is looking for patients with symptoms of respiratory infections like flu or COVID-19. Participants will provide nasal swabs for testing in a lab.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have symptoms of a respiratory infection
  • I am currently hospitalized or in a long-term care facility
  • My nasal sample is collected in the correct transport media
  • My sample is properly stored at the right temperature
  • I have at least 1.5 mL of leftover nasal sample
  • My nasal sample is in good condition

You may not be able to join if

  • I used the wrong type of swab for my sample
  • I used the wrong transport media for my sample
  • I did not store my sample at the right temperature
  • My sample has been frozen and thawed more than two times
  • I used calcium alginate or organic swabs for my sample

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The DiaSorin Molecular LIAISON® NES FLU A/B, RSV \& COVID-19 real-time polymerase chain reaction (RT-PCR) assay is intended for use on the DiaSorin LIAISON® NES instrument for the in-vitro qualitative detection and differentiation of nucleic acid from influenza A, influenza B, RSV and SARS-CoV-2 virus from dry nasal swabs (NS) from human patients with signs and symptoms during the acute phase of r…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * The specimen is a NPS or NS from a patient collected and preserved in 3 mL Universal Transport Media (UTM), BD Universal Viral Transport (UVT), or MicroTest M4RT transport media, or 1 mL Copan Eswab (Liquid Amies). * The specimen is from a patient who is either hospitalized, a…
Contacts

Janet Farhang

5124015472

janet.farhang@diasorin.com

CONTACT